IRTC:NASDAQiRhythm Holdings, Inc. Analysis
Data as of 2026-04-11 - not real-time
$115.24
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Technical outlook: The stock is trading below its short‑term moving averages, indicating a bearish price bias. Momentum indicators show a modestly bullish MACD histogram while the RSI sits in the lower‑mid range, suggesting limited upside momentum and potential oversold conditions. Volume trends are weakening, and the 30‑day volatility remains high, which together amplify short‑term risk.
Fundamental outlook: Revenue is expanding at a robust rate, yet profitability remains negative with slim operating margins and a negative net margin. Cash flow from operations is positive, providing a cushion despite a sizable debt load and an elevated debt‑to‑equity ratio. Valuation metrics are markedly above industry averages, and the discounted cash flow model points to a fair value well below the current market price. Recent news of a UnitedHealth executive joining the board and sizable institutional buying add a layer of strategic optimism, but the overall picture is one of a growth‑oriented company that is presently overvalued.
Fundamental outlook: Revenue is expanding at a robust rate, yet profitability remains negative with slim operating margins and a negative net margin. Cash flow from operations is positive, providing a cushion despite a sizable debt load and an elevated debt‑to‑equity ratio. Valuation metrics are markedly above industry averages, and the discounted cash flow model points to a fair value well below the current market price. Recent news of a UnitedHealth executive joining the board and sizable institutional buying add a layer of strategic optimism, but the overall picture is one of a growth‑oriented company that is presently overvalued.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price below short‑term moving averages
- high volatility and decreasing volume
- valuation gap versus DCF fair value
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- strong revenue growth but weak margins
- significant debt burden
- persistent overvaluation relative to peers
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- sustained top‑line growth and positive operating cash flow
- strategic board appointment enhancing payer relationships
- large and expanding cardiac monitoring market opportunity
Key Metrics & Analysis
Financial Health
Revenue Growth27.10%
Profit Margin-5.96%
P/E Ratio137.8
ROE-36.57%
ROA-2.36%
Debt/Equity478.69
P/B Ratio24.4
Op. Cash Flow$80.9M
Free Cash Flow$71.7M
Industry P/E26.0
Technical Analysis
TrendBearish
RSI38.6
Support$112.31
Resistance$125.00
MA 20$117.61
MA 50$131.51
MA 200$158.77
MACDBullish
VolumeDecreasing
Fear & Greed Index87.09
Valuation
Fair Value$77.85
Target Price$201.71
Upside/Downside75.04%
GradeOvervalued
TypeBlend
Risk Assessment
Beta0.82
Volatility35.33%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.